Web Content Management
PRODUCTS
-
As part of Bora Pharmaceuticals’ global growth strategy, the company successfully completed the acquisition of GSK's Mississauga, Ontario (Canada) facility in 2020. Representing Bora’s first manufacturing facility in North America and its headquarters in the region, the Mississauga site is integral to the company’s global contract development and manufacturing organization (CDMO) business offering.
-
Test of Homepage Bucket HTML In Product Document TypeTest of Homepage Bucket HTML In Product Document Type. Test of Homepage Bucket HTML In Product Document Type. Test of Homepage Bucket HTML In Product Document Type Test of Homepage Bucket HTML In Product Document Type.
Test of Homepage Bucket HTML In Product Document Type Test of Homepage Bucket HTML In Product Document Type.
-
Collect quality data from your patients remotely to launch smooth-running decentralized clinical trials and digital health studies
-
As a top Clinical Research Organization, ProPharma brings over 20 years of experience, innovation, personalization, and adaptability to Sponsors’ studies and research.
-
The AMP4072A solid-state, high-power amplifier has a broad frequency range of 26.5 to 40.0 GHz with a power output of 10 watt minimum and 12 watt typical in continuous wave (CW) or pulse mode at Psat, and 8 watt typical at P1dB.
WHITE PAPERS AND CASE STUDIES
-
eSource For A COVID Treatment Trial
Unearth how this emerging biopharmaceutical company was able to overcome challenges to successfully facilitate a Phase 2 trial for a COVID-19 treatment in critically ill patients.
-
Strategic Space Management
A pharmaceutical company facing storage space issues decided to outsource their reference samples to Q1 Scientific, a stability storage service provider, resulting in cost savings.
-
Patient Diversity Case Study: RWD Solutions
See how by leveraging medical claims and diversity data, this clinical trial sponsor was able to identify relevant patients meeting the trial’s I/E criteria, broken out by race and gender.
-
How MAC Clinical Research Innovates With CDMS/EDC
Discover how a partnership with one of Europe’s largest contract research organizations exemplifies the crucial role that technology plays in the realm of clinical studies.
-
Tackling Antimicrobial Resistance
Learn how three companies collaborated to develop a new antibiotic to address the increasing development of antimicrobial resistance (AMR) that threatens the global health landscape.
-
Scaling A Service Business In A Field Of Giant Competitors
There is no shortage of Davids in a world of service business Goliaths — fast-growing companies that are disrupting legacy incumbents by delivering an excellent customer experience. In the ISP (Internet Service Provider) industry, Sail Internet is one such company that is scaling fast and working to ensure it has adopted the digital tools it needs to future-proof the business. To explore some of the challenges that Sail Internet was facing and how it is navigating through digital transformation, we had a chance to chat with the company’s co-founder and CTO, George Ginis.
-
Accelerating Drug Product Development From Early Phase To Commercialization
This case study demonstrates rapid development, clinical assessment and commercial readiness of DRGT-46, a novel composition of Celecoxib, using integrated services.
-
Considerations For Pre-Filled Syringes For 503(b) Compounding Facilities
Industry experts weigh in on how to help 503(b) compounding facilities bring acute care drugs to market more quickly, provide a safer drug administration process, and minimize health care and hospital costs.
-
How The World's Leading Vaccine Network Reduced Protocol Deviations
Discover how the world's leading vaccine site network reduced protocol deviations by almost 40%.
-
Standardizing Content Management Across The Life Sciences Industry
Explore a quality reference model that aims to foster further standardization within the life sciences industry, and discover the advantages of leveraging the standardized best practices within.
-
Biotechnology Manufacturing Program Management
Find out how a global biotechnology manufacturing company executing several interrelated projects achieved critical project objectives while adhering to schedule and financial commitments.
-
Formulation Development Strategy For Early Phase Human Studies
Determining bioavailable formulation for animal PK, GLP toxicity, first-in-human, and first-in-patient is challenging. Drug delivery systems are usually used for poorly soluble and bioavailable compounds.
NEWS
-
NIH Funds Consortium To Accelerate Development Of New TB Treatments7/8/2024
A new consortium co-led by Weill Cornell Medicine, has been awarded a five-year, $31M grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases to accelerate the development of faster, more effective treatment regimens for tuberculosis (TB).
-
Daxor Expands To Three New Facilities As Blood Volume Analysis Technology Gains Momentum Nationwide8/5/2024
Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces the expansion of blood volume analysis (BVA) in three new facilities.
-
Genesis HealthCare System Builds On Its Investment In BIO-key Biometric Authentication Security As It Migrates To Epic Hyperdrive12/14/2023
BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication solutions, announced that its longstanding customer Genesis HealthCare System, the largest healthcare provider in its six-county region of Ohio, will add BIO-key’s PortalGuard IAM platform to support its existing BIO-key biometric authentication investment as it migrates to Epic Systems’ Hyperdrive end-user application interface
-
Eni Concludes Kenya Bootcamp 'Seeds For Sustainable Energy'5/15/2023
In recent days, Eni promoted the “Seeds for sustainable energy” bootcamp in Kenya, a joint open innovation initiative involving Joule, Eni's Business School and the company's Tech Open Innovation and agroenergy areas.
-
Weill Cornell Medicine Receives Grant For Blood Test To Diagnose Breast Cancer1/3/2024
Weill Cornell Medicine researchers received a $2.4M grant from the U.S. Department of Defense Breast Cancer Research Program to validate a new blood test for the early detection of breast cancer.